Skip to main content

and
  1. No Access

    Article

    Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment

    CD19 CAR-T (chimeric antigen receptor-T) cell immunotherapy achieves a remission rate of approximately 70% in recurrent and refractory lymphoma treatment. However, the loss or reduction of CD19 antigen on the ...

    Wei-Wei Zheng, Hang Zhou, ** Li, Shi-Guang Ye in Cancer Immunology, Immunotherapy (2023)

  2. No Access

    Article

    NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1

    Gliomas and their surrounding microenvironment constantly interact to promote tumorigenicity, yet the underlying posttranscriptional regulatory mechanisms that govern this interplay are poorly understood.

    Venkata Soumith Jonnakuti, ** Ji, Yipeng Gao, Ai Lin in Journal of Neuro-Oncology (2023)

  3. No Access

    Article

    O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma

    Aberrantly elevated O-GlcNAcylation level is commonly observed in human cancer patients, and has been proposed as a potential therapeutic target. Speckle-type POZ protein (SPOP), an important substrate adaptor...

    Peng Zhou, Wen-yi Chang, De-ao Gong, Lu-yi Huang, Rui Liu, Yi Liu, Jie **a in Oncogene (2023)

  4. No Access

    Article

    Upregulation of TUBG1 expression promotes hepatocellular carcinoma development

    Tubulin γ-1 (TUBG1) is a highly conserved component of the centrosome and its deregulation is involved in the development of several types of cancer. However, the role of TUBG1 in hepatocellular carcinoma (HCC) r...

    Zi-jian Wang, Zhi-zheng Dai, Mei-zhen Hu, Jun-nan Liu, Hang Liang in Medical Oncology (2023)

  5. Article

    Open Access

    Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

    The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-spe...

    **-Ya Li, Ji-Chuan Wu, ** Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen in Leukemia (2023)

  6. Article

    Open Access

    Knockdown of RAD51AP1 suppressed cell proliferation and invasion in esophageal squamous cell carcinoma

    Esophageal cancer is a common malignant tumor of digestive tract with esophageal squamous cell carcinoma (ESCC) being the main histological subtype. This study aimed to identify potential hub gene associated w...

    Yang-Yang Hu, Chen-Chao Ma, Kai-**ng Ai in Discover Oncology (2022)

  7. No Access

    Article

    Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study

    Thyroid hormone withdrawal (THW) inevitably induced hypothyroidism in patients with differentiated thyroid cancer (DTC), and we aimed to evaluate the safety and efficacy of a novel recombinant human thyroid-st...

    Yan-Song Lin, Hui Yang, **ao-Yi Li in European Journal of Nuclear Medicine and M… (2022)

  8. No Access

    Article

    Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy

    Although chimeric antigen receptor T-cell (CAR-T) therapy produces a high complete remission rate among patients with relapsed/refractory B-cell acute lymphoblastic leukemia, relapse remains an urgent issue. I...

    Guan-Hua Hu, **ang-Yu Zhao, Ying-** Zuo, Ying-Jun Chang, Pan Suo, Jun Wu in Leukemia (2021)

  9. Article

    Open Access

    Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products

    Chang-Long He, Lu-Yi Huang, Kai Wang in Signal Transduction and Targeted Therapy (2021)

  10. Article

    Open Access

    Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment

    Pediatric acute myeloid leukemia (AML) with t(8;21) (q22;q22) is classified as a low-risk group. However, relapse is still the main factor affecting survival. We aimed to investigate the effect of allogeneic h...

    Guan-hua Hu, Yi-fei Cheng, Ai-dong Lu, Yu Wang, Ying-xi Zuo, Chen-hua Yan in BMC Cancer (2020)

  11. No Access

    Article

    Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

    PEG-rhG-CSF reduces neutropenia and improves chemotherapy safety. In China’s registration trial (CFDA: 2006L01305), we assessed its efficacy and safety against rhG-CSF, and prospectively explored its value ove...

    Jie **e, Jun Cao, **g-fen Wang, Bai-hong Zhang in Breast Cancer Research and Treatment (2018)

  12. No Access

    Article

    The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group

    This study compared 6-year follow-up data from patients undergoing reduced-intensity conditioning (RIC) transplantation with an HLA-matched related donor (MRD), an HLA-matched unrelated donor (MUD), or an HLA-...

    Chang-Lin Yu, Zheng-Dong, Zhen-Hua Qiao, Jian-Min Wang, Huang-He in Annals of Hematology (2017)

  13. No Access

    Article

    PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms

    Protein phosphatase, Mg2+/Mn2+ dependent, 1D (PPM1D) is emerging as an oncogene by virtue of its negative control on several tumor suppressor pathways. However, the clinical significance of PPM1D in pancreatic ca...

    Bo Wu, Bo-Min Guo, Jie Kang, **an-Zhao Deng, You-Ben Fan, **ao-** Zhang in Apoptosis (2016)

  14. No Access

    Article

    Different Expression of S100A8 in Malignant and Benign Gallbladder Diseases

    Proteomic analysis is a powerful tool for complete establishment of protein expression. Comparative proteomic analysis of human bile from malignant and benign gallbladder diseases may be helpful in research in...

    Wei Wang, Kai-**ng Ai, Zhou Yuan, **n-Yu Huang in Digestive Diseases and Sciences (2013)

  15. No Access

    Article

    Increased Frequency of Circulating Th17 Cells in Acute-on-Chronic Hepatitis B Liver Failure

    T helper (Th) 17 cells participate in the pathogenesis of liver diseases but their exact role in acute-on-chronic hepatitis B liver failure (ACHBLF) still remains obscure.

    Li-Yuan Wang, Qing-Hua Meng, Zhi-Qiang Zou, Yu-Chen Fan in Digestive Diseases and Sciences (2012)

  16. Article

    Open Access

    Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice

    Liver resection is a widely accepted treatment for hepatocellular carcinoma (HCC). Our previous clinical study showed that the rate of palliative resection was 34.0% (1958-2008, 2754 of 8107). However, the inf...

    **u-Yan Huang, Zi-Li Huang, Lu Wang, Yong-Hua Xu, **n-Yu Huang, Kai-**ng Ai in BMC Cancer (2010)

  17. No Access

    Article

    Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma

    To examine the expressions of focal adhesion kinase (FAK) and its clinical significance in hepatocellular carcinoma (HCC).

    Zhou Yuan, Qi Zheng, Jia Fan, Kai-xing Ai in Journal of Cancer Research and Clinical On… (2010)